William Deraedt

5PUBLICATIONS
22CO-AUTHORS
Medical mycologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2024
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.

Binod Dhakal, Hermann Einsele, Jordan M Schecter

|Oct 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.

Tom Martin, Saad Z Usmani, Jordan M Schecter

|Sep 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents.

Adam D Cohen, María-Victoria Mateos, Yael C Cohen

|Jul 14, 2021
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.

Tom Martin, Saad Z Usmani, Jordan M Schecter

|Nov 06, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison.

Maria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt

Pageof 1

Frequent Collaborators

2 joint publications

Maria-Victoria Mateos

2 joint publications

Jesus San-Miguel

2 joint publications

Imtiaz A Samjoo

2 joint publications

Jianming He